ArticleBMJ open2025

Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial.

Melanie Varley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.